BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 30059495)

  • 1. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
    Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
    PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent Feature Decompositions for Integrative Analysis of Multi-Platform Genomic Data.
    Gregory KB; Momin AA; Coombes KR; Baladandayuthapani V
    IEEE/ACM Trans Comput Biol Bioinform; 2014; 11(6):984-94. PubMed ID: 26146492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
    Sintupisut N; Liu PL; Yeang CH
    Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Systemic Analysis of Transcriptomic and Epigenomic Data To Reveal Regulation Patterns for Complex Disease.
    Xu C; Zhang JG; Lin D; Zhang L; Shen H; Deng HW
    G3 (Bethesda); 2017 Jul; 7(7):2271-2279. PubMed ID: 28500050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative network-based Bayesian analysis of diverse genomics data.
    Wang W; Baladandayuthapani V; Holmes CC; Do KA
    BMC Bioinformatics; 2013; 14 Suppl 13(Suppl 13):S8. PubMed ID: 24267288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
    Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
    Liu C; Wang X; Genchev GZ; Lu H
    Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of micro-RNA, gene expression, and survival of glioblastoma multiforme.
    Huang YT; Hsu T; Kelsey KT; Lin CL
    Genet Epidemiol; 2015 Feb; 39(2):134-43. PubMed ID: 25537983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data.
    Wang W; Baladandayuthapani V; Morris JS; Broom BM; Manyam G; Do KA
    Bioinformatics; 2013 Jan; 29(2):149-59. PubMed ID: 23142963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
    Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
    Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.
    Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK
    Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSVD comparison of patient-matched normal and tumor aCGH profiles reveals global copy-number alterations predicting glioblastoma multiforme survival.
    Lee CH; Alpert BO; Sankaranarayanan P; Alter O
    PLoS One; 2012; 7(1):e30098. PubMed ID: 22291905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-relation reconstruction from inter-relation: miRNA to gene expression.
    Kim D; Shin H; Joung JG; Lee SY; Kim JH
    BMC Syst Biol; 2013 Oct; 7 Suppl 3(Suppl 3):S8. PubMed ID: 24521265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
    Lehrer S; Rheinstein PH; Rosenzweig KE
    Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local network component analysis for quantifying transcription factor activities.
    Shi Q; Zhang C; Guo W; Zeng T; Lu L; Jiang Z; Wang Z; Liu J; Chen L
    Methods; 2017 Jul; 124():25-35. PubMed ID: 28710010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
    Fatai AA; Gamieldien J
    BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epigenetic biomarker panel for glioblastoma multiforme personalized medicine through DNA methylation analysis of human embryonic stem cell-like signature.
    Chiang JH; Cheng WS; Hood L; Tian Q
    OMICS; 2014 May; 18(5):310-23. PubMed ID: 24601786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biobanking: An Important Resource for Precision Medicine in Glioblastoma.
    Tan SY; Sandanaraj E; Tang C; Ang BT
    Adv Exp Med Biol; 2016; 951():47-56. PubMed ID: 27837553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-analyte network markers for tumor prognosis.
    Kim J; Gao L; Tan K
    PLoS One; 2012; 7(12):e52973. PubMed ID: 23300836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
    Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.